LifeMD Inc (LFMD)
5.69
+0.27
(+4.98%)
USD |
NASDAQ |
Nov 21, 16:00
5.69
0.00 (0.00%)
After-Hours: 16:16
LifeMD Price: 5.69 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 5.54 | 5.71 | 5.37 | 5.42 | 341376.0 |
Nov 19, 2024 | 5.24 | 5.605 | 5.20 | 5.56 | 459082.0 |
Nov 18, 2024 | 5.45 | 5.53 | 5.24 | 5.26 | 660439.0 |
Nov 15, 2024 | 6.00 | 6.15 | 5.425 | 5.485 | 1.115M |
Nov 14, 2024 | 6.70 | 6.90 | 5.96 | 5.97 | 1.348M |
Nov 13, 2024 | 7.29 | 7.54 | 6.91 | 6.99 | 757012.0 |
Nov 12, 2024 | 7.04 | 7.31 | 6.78 | 7.16 | 896793.0 |
Nov 11, 2024 | 6.12 | 7.43 | 6.05 | 7.10 | 2.203M |
Nov 08, 2024 | 5.50 | 6.14 | 5.34 | 5.85 | 1.735M |
Nov 07, 2024 | 4.96 | 5.19 | 4.84 | 5.13 | 594643.0 |
Nov 06, 2024 | 4.80 | 5.095 | 4.60 | 5.06 | 650100.0 |
Nov 05, 2024 | 4.39 | 4.49 | 4.20 | 4.46 | 579163.0 |
Nov 04, 2024 | 4.29 | 4.50 | 4.22 | 4.38 | 330833.0 |
Nov 01, 2024 | 4.09 | 4.38 | 4.09 | 4.32 | 407150.0 |
Oct 31, 2024 | 4.18 | 4.24 | 4.03 | 4.08 | 362997.0 |
Oct 30, 2024 | 4.28 | 4.34 | 3.99 | 4.15 | 1.058M |
Oct 29, 2024 | 4.39 | 4.39 | 4.26 | 4.31 | 200703.0 |
Oct 28, 2024 | 4.35 | 4.46 | 4.32 | 4.395 | 241340.0 |
Oct 25, 2024 | 4.29 | 4.47 | 4.255 | 4.29 | 217877.0 |
Oct 24, 2024 | 4.40 | 4.40 | 4.22 | 4.25 | 267776.0 |
Oct 23, 2024 | 4.39 | 4.56 | 4.30 | 4.39 | 390763.0 |
Oct 22, 2024 | 4.61 | 4.61 | 4.41 | 4.42 | 291027.0 |
Oct 21, 2024 | 4.75 | 4.79 | 4.47 | 4.49 | 557378.0 |
Oct 18, 2024 | 4.60 | 4.79 | 4.60 | 4.68 | 349885.0 |
Oct 17, 2024 | 4.75 | 4.755 | 4.53 | 4.58 | 249004.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.506
Minimum
Mar 12 2020
30.55
Maximum
Feb 17 2021
5.458
Average
4.60
Median
Oct 27 2021
Price Benchmarks
Veradigm Inc | 10.99 |
TruBridge Inc | 16.01 |
Streamline Health Solutions Inc | 3.025 |
LENZ Therapeutics Inc | 34.33 |
Oruka Therapeutics Inc | 20.45 |
Price Related Metrics
PS Ratio | 1.174 |
Price to Free Cash Flow | 21.33 |
Earnings Yield | -11.25% |
Market Cap | 246.45M |